'Win-win': CT health experts praise Pfizer trial showing vaccine's effectiveness on adolescents
Local health experts praised a new trial from Pfizer-BioNTech that shows its vaccine had 100 percent efficacy among participants ages 12 to 15.
Local health experts praised a new trial from Pfizer-BioNTech that shows its vaccine had 100 percent efficacy among participants ages 12 to 15.